Literature DB >> 2433769

Immunological self, nonself discrimination.

J G Guillet, M Z Lai, T J Briner, S Buus, A Sette, H M Grey, J A Smith, M L Gefter.   

Abstract

The ability of immunodominant peptides derived from several antigen systems to compete with each other for T cell activation was studied. Only peptides restricted by a given transplantation antigen are mutually competitive. There is a correlation between haplotype restriction, ability to bind to the appropriate transplantation antigen, and ability to inhibit activation of other T cells restricted by the same transplantation antigen. An exception was noted in that a peptide derived from an antigen, bacteriophage lambda cI repressor, binds to the I-Ed molecule in a specific way, yet is not I-Ed-restricted. Comparison of the sequence of the repressor peptide with that of other peptides able to bind to (and be restricted by) I-Ed and a polymorphic region of the I-Ed molecule itself revealed a significant degree of homology. Thus, peptides restricted by a given class II molecule appear to be homologous to a portion of the class II molecule itself. The repressor-derived peptide is identical at several polymorphic residues at this site, and this may account for the failure of I-Ed to act as a restriction element. Comparison of antigenic peptide sequences with transplantation antigen sequences suggests a model that provides a basis for explaining self, nonself discrimination as well as alloreactivity.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2433769     DOI: 10.1126/science.2433769

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  68 in total

1.  Selection for class II Mhc heterozygosity by parasites in subterranean mole rats.

Authors:  E Nevo; A Beiles
Journal:  Experientia       Date:  1992-05-15

Review 2.  T cells causing immunological disease.

Authors:  R M Zinkernagel; H Pircher; P S Ohashi; H Hengartner
Journal:  Springer Semin Immunopathol       Date:  1992

Review 3.  Interactions between immunogenic peptides and HLA-DR molecules.

Authors:  J B Rothbard; R Busch
Journal:  Immunol Res       Date:  1990       Impact factor: 2.829

4.  Rapid typing of HLA-DQB1 DNA polymorphism using nonradioactive oligonucleotide probes and amplified DNA.

Authors:  T L Bugawan; H A Erlich
Journal:  Immunogenetics       Date:  1991       Impact factor: 2.846

5.  Multiple B- and T-cell epitopes on a major allergen of Kentucky Bluegrass pollen.

Authors:  L Zhang; M Yang; P Chong; S S Mohapatra
Journal:  Immunology       Date:  1996-02       Impact factor: 7.397

6.  Norepinephrine inhibits gamma-interferon-induced major histocompatibility class II (Ia) antigen expression on cultured astrocytes via beta-2-adrenergic signal transduction mechanisms.

Authors:  E M Frohman; B Vayuvegula; S Gupta; S van den Noort
Journal:  Proc Natl Acad Sci U S A       Date:  1988-02       Impact factor: 11.205

7.  Cloning and physical mapping of the HLA class I region spanning the HLA-E-to-HLA-F interval by using yeast artificial chromosomes.

Authors:  D E Geraghty; J Pei; B Lipsky; J A Hansen; P Taillon-Miller; S K Bronson; D D Chaplin
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-01       Impact factor: 11.205

8.  Modulation of T cell responses with MHC-derived peptides.

Authors:  W V Williams; D B Weiner; M A Borofsky; D H Rubin; K Yui; M I Greene
Journal:  Immunol Res       Date:  1992       Impact factor: 2.829

9.  Proliferative T-cell response to glycoprotein B of the human herpes viruses: the influence of MHC and sequence of infection on the pattern of cross-reactivity.

Authors:  W L Chan; M L Tizard; L Faulkner
Journal:  Immunology       Date:  1989-09       Impact factor: 7.397

10.  A specific HLA-DP beta allele is associated with pauciarticular juvenile rheumatoid arthritis but not adult rheumatoid arthritis.

Authors:  A B Begovich; T L Bugawan; B S Nepom; W Klitz; G T Nepom; H A Erlich
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.